internship 1 4
TRANSCRIPT
INTERNSHIP 1
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
EXERCISE 1
GENERAL
REQUIREMENTS FOR
ISSUANCE OF LTO
BY BFAD
TERMS TO DEFINE
PHARMACY
DRUGS
POISON
CODE
BIOLOGIC PRODUCTS
WHOLESALER
DEVICE
CIPHER
SECRET KEYS
PHARMACEUTICAL MEDICINES
REQUIREMENTS FOR OPENING A
DRUGSTORE UNDER “PREMISES”
Signboard
Well ventilated area nlt 15 sq.m.
Compounding area, sterilization area
Storage area for drugs
Cabinet ( poisons, DD)
Water supplies
REQUIREMENTS FOR OPENING A
DRUGSTORE UNDER “UTENSILS,
APPARATUS, & EQUIPMENT”
Refrigerator
BIO-REF
REQUIREMENTS FOR RENEWAL
OF LTO
Standard Petition Form –name, citizenship,
picture, proposed area
Proof of registration
Single proprietorship –cert. of business name
registration (BDT of DTI)
Partnerships, corporations – cert. of
registration (SEC) and articles of Incorporation
or partnership
REQUIREMENTS FOR
DRUGSTORE/RETAIL OUTLET FOR
NON-RX DRUGS Notarized petition/Joint affidavit
Tentative list of products
Floor area (nlt 15 sq.m)
Generic white and red labels
Rubber stamp of outlets
Pharmacist Registration cert.
PRC-ID
valid PTR
ID picture
cert. of attendance to BFAD seminar
Single proprietorship
Corporation
Contract of lease
Picture of drugstore with signboard
Location plan and floor plan with dimension
Opening fee ( A.O. 50 s. 2001)
Requirement
Petition Form
Requirement
Joint Affidavit of
Undertaking
List of Tentative Products
Example
Paracetamol
Biogesic
Tempra
Tylenol
Winadol
Acetadol
Rexidol
License To Operate
Pharmacist
Registration of
certificate
Pharmacist
Business Registration
Pharmacist
PRC ID
Pharmacist
Certificate of attendance
REFERENCE BOOKS
PNDF
RA 3720
RA 6675
RA 5921
RA 8203
USP/NF
RPS
Goodman and Gilman Pharmacological Basis of Therapeutics
Reference Book
Philippine National Drug
Formulary
Reference Book
Remington
Pharmaceutical
Sciences
Reference Book
UNITED STATE
PHARMACOPEIA
RECORD BOOKS
Prescription Book
Dangerous Drug Book
Poison Book
Exempt Preparation Book
Prescription Book
Prescription Book
Dangerous Drugs Book
POISON/CHEMICAL BOOK
DANGEROUS DRUG BOOK
OPIUM BOOK
PRESCRIPTION BOOK
INTERNSHIP 1
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
EXERCISE NO. 2
THE CONTROL OF PHARMACY PROFESSION
STATUTORY LAW
COMMON LAW
ETHICS
REGULATORY LAW
JURISPRUDENCE
Terms To Define
STATUTORY LAWS AFFECTING
PHARMACY PROFESSION
RA 5921 – JUNE 22, 1969
RA 3720 – JUNE 23, 1963
RA 8203 – SEPT 4, 1996
RA 6675 – 1988
RA 9165 – 2002, repealing RA 6425
RA 9257 (Expanded Senior Citizen Act) – amending RA 7432
RA 7581 – PRICE ACT
RA 7394 – CONSUMERS ACT
is an act regulating the
practice of pharmacy and
setting standards of
pharmaceutical education in
the Philippines and other
purposes
THE PHARMACY LAW – R.A. 5921
this is an act to ensure the safety
and purity of foods and cosmetics,
and the purity, safety, efficacy, and
quality of drugs and devices being
made available to the public vesting
the BFAD with authority to administer
and enforce the laws pertaining
thereto
THE FOODS, DRUGS & DEVICES – R.A. 3720
It is an act prohibiting counterfeit
drugs, providing penalties for
violations and appropriating funds.
The BFAD of the Department of
Health is authorized to administer
and supervise the implementation of
this Act which was approved on
September 4, 1996.
SPECIAL LAW ON COUNTERFEIT
DRUGS – R.A. 8203
It is act to promote, require, and
ensure the production of an
adequate supply, distribution, use
and acceptance of drugs and
medicines identified by their
generic names.
THE GENERICS ACT – R.A. 6675
It is an act instituting the
Comprehensive Dangerous
Drugs Act of 2002, repealing
Republic Act No. 6425,
otherwise known as the
Dangerous Drugs Act of 1972
COMPREHENSIVE DANGEROUS
DRUG ACT – R.A. 9165
An act granting additional benefits
and privileges to senior citizens
amending for the purpose RA No.
7432, otherwise known as “An act to
maximize the contribution of senior
citizens to nation building, grant
benefits and special privileges and for
other purposes
EXPANDED SENIOR CITIZEN ACT –
R.A. 9257
. An act providing protection to
consumers by stabilizing the prices of
basic necessities and prime
commodities and by prescribing
measures against undue price
increases during emergency situations
and like occasions
THE PRICE ACT – R.A. 7581
. It is an act to protect the
interest of the consumer,
promote his general welfare
and to establish standards of
conduct for business and
industry.
CONSUMERS ACT – R.A. 7394
PRINCIPLES OF PROFESSIONAL
CONDUCT
Service to others
Integrity and Objectivity
Professional competence
Solidarity and teamwork
Social and civic responsibility
Global competitiveness
Equality of all professions
CODE OF ETHICS
IMPORTANCE
States publicly the principles that form the
fundamental basis of pharmacists’ roles and
responsibilities
Guides them in their relationship with patients,
health professionals and society
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
INTERNSHIP 1
EXERCISE 3
THE COMMUNITY
PHARMACY
PROFILE
TRADITIONAL MARKET
DRUGSTORE
PERSONNEL
STORE HOURS
NON-TRADITIONAL MARKET
STORE FRONT LAYOUTS
DRUGSTORE CHAIN OPERATION
MERCHANDISE &SERVICES
WAYS OF DEVELOPING COMPETITIVE
ADVANTAGES IN COMMUNITY
PHARMACY
Product line assortment
Leader pricing strategy
Innovation of operation
Customer services
Equipment /facilities
COMPARISON OF COMMUNITY
PHARMACY IN 1990’S AND 2000’S
Location
signboards
Store front and interiors
Staffing pattern
Pharmacist
Communication
Store facilities
Capitalization
Transportation
BEING FIRST TO INTRODUCE
“24 HOUR SERVICE”
BEING FIRST – MOTORIZED
CUSTOMER DELIVERY
BEING FIRST – COMPUTERIZED
TEMPERATURE CONTROLLED WAREHOUSE
BEING FIRST – COMMUNITY PHARMACY
INSIDE SHOPPING MALLS AND
SUPERMARKETS
BEING FIRST – MODERNIZE STORE FRONT,
INTERIORS WAREHOUSE AND LAYOUT
BEING FIRST – “MEDICAL-PHARMACY
OUTREACH MISSION”
BEING FIRST – “DRUGSTORE CHAIN
TO EXPAND THROUGHOUT”
BEING FIRST – PROFESSIONALIZE ITS
PERSONNEL
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
INTERNSHIP 1
Exercise 4
THERAPEUTIC
CATEGORIES OF
DRUGS BY PNDF
PNDF
DANGEROUS DRUGS
BFAD
THERAPEUTIC COMMITTEES
CORE/ MAIN LIST
COMPLEMENTARY LIST
GENERAL GUIDELINES FOR
ESTABLISHING PNDF
Relevance to disease
Efficacy and safety
Quality
Cost
Appropriateness to capability of health
workers at different levels of health care
Local health problems
Benefit/risk ratio
Preferential factors for evaluating
therapeutically equivalent drugs
Drugs formulated as single compounds
Period review of drug list
Criteria for inclusion of drugs into
PNDF
Drug is needed for prevention and Tx of
conditions not already covered in existing list
Drug is more effective / less toxic than the
drug listed for same medication
Drug is at least as effective and safe and of
lower cost than the drug listed for same
indication
Drug is essential for specific DOH health
project
Criteria for deletion of drugs from
PNDF
A more effective or equally effective but less
toxic drug becomes available
The therapeutic efficacy of drug is found to be
unsatisfactory or questionable
Toxicity/suspected toxicity or potential for
abuse or dangerous interactions outweigh its
therapeutic value
Disuse of drug and no longer available
The drug is no longer deemed cost-effective
to other therapies
The drug is a fixed dose combination which
does not satisfy the requirements of AO 96 s.
1990
Core List
Acetylcysteine Ergocalciferol
Azathioprine Fluorecein
Clofazimine Folic acid
Cobra antivenin Hydrochlorthiazide
Dantrolene Hydrocortisone
Diazepam Hydroxycobalamine
Diethylcarbamazepine Indomethacin inj
Diphtheria-tetanus toxoids Iodine
Dimercaprol INH + ethambutol
endrophonium INH + rifampicin
INH+ Rifampicin+ PZA Praziquantrel
Levodopa + Thiacetazone Retinol
Lorazepam Na Ca edetate
Methylene blue NaI 131I
N-acetyl penicillamine Na nitrite
Neostigmine Na nitroprusside
Nicotinamide Na thiosulfate
ORS 75 –replacement Succimer
Potassium Thiamine
Pot. phosphate Tuberculin purified protein
derivative
Complementary List
Aciclovir eye ointment Hydroxycobalamin
Alpha-tocopherol Indomethacin
Al acetate Iodamide
Cromolyn Iron dextran
Buserelin Povidone iodide
Busulfan Pralidoxime Cl
Chloral hydrate Pyrimethamine
Chlormethine Recombinant tissue
plasminogen activator
Dithranol Rifabutin
estramustine Rose bengal
Silver nitrate Varicella zoster Ig
Spectinomycin Vasopressin
Terizodone Yerba buena
Tetracosactide Zinc
Thiacetazone
Drugs in PNDF with special
requirements
Dangerous Drugs (A1)
Alprazolam Morphine
Bromazepam Nalbuphine
Butorphanol Oxycodone
Clonazepam Pethidine (meperidine)
Codein Phenobarbital
Diazepam Thiopenthal Na
Fentanyl Tramadol
Lorazepam Zolpidem
Methylphenidate
midazolam
Controlled precursors and Essential
chemicals (A2)
Ephedrine
Ergotamine
PPA
Medicinal products listed with BFAD
Akapulko
Lagundi
Sambong
Tsaang gubat
Yerba buena